GlassScriptPhysician profile
Scott M Barron
NPI 1316944259
$23,275.42
in general payments reported to CMS, 2019-2025
82 companies · $4,283 in 2025
The $4,283 reported for 2025 was more than what 80% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $2,715 · 2021: $3,368 · 2022: $3,405 · 2023: $3,632 · 2024: $3,461 · 2025: $4,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,733.79 |
| Education | $641.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,689.16 | 2020-2025 | |
| Daiichi Sankyo INC. | $1,282.90 | 2019-2025 | Enhertu, Vanflyta, Injectafer |
| Merck Sharp & Dohme LLC | $1,279.13 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Astrazeneca Pharmaceuticals LP | $1,158.97 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Janssen Biotech, INC. | $1,122.81 | 2019-2025 | Darzalex, Talvey, Tecvayli |
| Pfizer INC. | $993.13 | 2019-2025 | |
| Incyte Corporation | $921.57 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Amgen INC. | $822.14 | 2019-2023 | Kyprolis, Blincyto, Lumakras |
| Genentech USA, INC. | $768.62 | 2019-2025 | Polivy, Tecentriq, Phesgo |
| Eisai INC. | $747.26 | 2019-2025 | |
| Celgene Corporation | $666.97 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $646.82 | 2019-2025 | Opdivo |
| Abbvie INC. | $609.00 | 2019-2025 | Venclexta, Viberzi, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $590.49 | 2019-2025 | Iclusig, Fruzaqla, Ninlaro |
| Astellas Pharma US INC | $583.31 | 2019-2025 | Xtandi, Vyloy, Padcev |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $574.92 | 2019-2025 | |
| Glaxosmithkline, LLC. | $507.76 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Gilead Sciences, INC. | $472.91 | 2019-2025 | Trodelvy |
| Genzyme Corporation | $454.23 | 2019-2025 | |
| Exelixis INC. | $403.23 | 2019-2025 | Cabometyx |
| Pharmacyclics LLC, An Abbvie Company | $334.85 | 2019-2023 | Imbruvica |
| Beigene USA, INC. | $328.14 | 2020-2025 | Brukinsa |
| Lilly USA, LLC | $306.57 | 2019-2025 | Verzenio, Jaypirca |
| Seagen INC. | $295.34 | 2020-2025 | Tukysa, Adcetris |
| Ipsen Biopharmaceuticals, INC | $288.52 | 2019-2025 | Somatuline Depot, Onivyde |
| Regeneron Healthcare Solutions, INC. | $273.71 | 2019-2025 | Libtayo, Lynozyfic |
| Aveo Pharmaceuticals, INC. | $270.03 | 2021-2025 | Fotivda |
| Kite Pharma, INC. | $267.25 | 2020-2023 | Yescarta |
| Emd Serono, INC. | $254.48 | 2019-2025 | Bavencio |
| Blueprint Medicines Corporation | $248.34 | 2020-2025 | Ayvakit |
| Rigel Pharmaceuticals, INC. | $246.61 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Jazz Pharmaceuticals INC. | $231.06 | 2019-2025 | |
| Array Biopharma INC | $191.85 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Stemline Therapeutics INC. | $183.90 | 2023-2025 | Orserdu |
| Janssen Pharmaceuticals, INC | $177.85 | 2019-2024 | Xarelto |
| Springworks Therapeutics, INC. | $160.67 | 2024-2025 | Ogsiveo |
| Teva Pharmaceuticals USA, INC. | $158.57 | 2019-2022 | |
| Pharmaessentia USA Corporation | $146.49 | 2023-2025 | Besremi |
| Puma Biotechnology, INC. | $143.64 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.83 | 2019-2025 | Gilotrif |
| Alexion Pharmaceuticals, INC. | $141.56 | 2019-2025 | Ultomiris |
| Taiho Oncology, INC. | $136.18 | 2019-2025 | |
| Pharmacosmos Therapeutics INC. | $134.57 | 2021-2025 | Monoferric, Cosela |
| Sun Pharmaceutical Industries INC. | $133.07 | 2021-2023 | Yonsa, Odomzo |
| Servier Pharmaceuticals LLC | $123.08 | 2022-2025 | |
| Clovis Oncology, INC. | $95.13 | 2019-2021 | |
| Agios Pharmaceuticals, INC. | $90.26 | 2023-2025 | Pyrukynd |
| Genmab U.S., INC. | $84.38 | 2023-2025 | Tivdak, Epkinly |
| Adc Therapeutics America, INC. | $83.63 | 2022-2025 | |
| Sobi, INC | $83.39 | 2022-2025 | |
| Beone Medicines USA, INC. | $81.30 | 2025 | Brukinsa |
| Tersera Therapeutics LLC | $80.68 | 2021-2025 | Zoladex |
| Karyopharm Therapeutics INC. | $79.25 | 2020-2022 | |
| Adaptive Biotechnologies Corporation | $76.75 | 2023-2025 | Clonoseq |
| Mirati Therapeutics, INC. | $71.93 | 2023 | Krazati |
| G1 Therapeutics, INC. | $71.15 | 2022-2023 | Cosela |
| Dova Pharmaceuticals | $65.86 | 2019-2021 | |
| Tesaro, INC. | $64.39 | 2019 | |
| Acceleron Pharma, INC. | $48.02 | 2020-2021 | |
| Geron Corporation | $47.03 | 2025 | Rytelo |
| Recordati_rare_diseases_inc. | $42.82 | 2024 | Sylvant |
| Apellis Pharmaceuticals, INC. | $42.00 | 2023 | Empaveli |
| Heron Therapeutics, INC. | $37.08 | 2022 | |
| Epizyme, INC. | $35.64 | 2020-2021 | |
| Cti Biopharma Corp. | $33.86 | 2023 | Vonjo |
| Progenics Pharmaceuticals, INC. | $30.90 | 2023 | Pylarify |
| Immunocore Limited | $30.63 | 2025 | Kimmtrak |
| Aurobindo Pharma USA, INC. | $29.91 | 2020 | |
| Coherus Oncology, INC. | $28.46 | 2020-2021 | |
| Legend Biotech USA INC. | $26.68 | 2025 | Carvykti |
| Kyowa Kirin, INC. | $24.73 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $22.52 | 2024 | Provenge |
| Eusa Pharma (US) LLC | $21.95 | 2019 | |
| Tg Therapeutics, INC. | $19.33 | 2021 | |
| Foundation Medicine, INC. | $17.88 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $14.96 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.75 | 2023 | Givlaari |
| Azurity Pharmaceuticals, INC. | $13.93 | 2025 | Danziten, Vivimusta |
| Partner Therapeutics, INC. | $13.54 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $12.70 | 2019 | |
| Verastem, INC. | $12.45 | 2020 | |
| Myriad Genetic Laboratories, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
Enhertu $629Keytruda $478Kisqali $458Lenvima $366Darzalex $365Jakafi $348Imbruvica $280Opdivo $276Polivy $258Tecentriq $254Vanflyta $238Brukinsa $230Lynparza $217Nubeqa $207Zejula $201Jemperli $201Cabometyx $200Tukysa $195Xtandi $192Ibrance $185Orserdu $184Fotivda $183Reblozyl $180Braftovi $171Imfinzi $164Piqray $164Talvey $162Ogsiveo $161Welireg $160Jaypirca $159Verzenio $159Mektovi $159Stivarga $156Vitrakvi $156Besremi $146Elrexfio $146Tecvayli $146Zepzelca $144Epkinly $143Xofigo $142Calquence $138Tavalisse $135Rezlidhia $135Adcetris $135Fabhalta $134Phesgo $130Trodelvy $129Venclexta $128Ojjaara $125Libtayo $120Ultomiris $114Erleada $107Padcev $106Cosela $104Lorbrena $102Bosulif $94.85Scemblix $92.00Pyrukynd $90.26Pomalyst $82.69Injectafer $78.84Iclusig $78.65Talzenna $76.81Clonoseq $76.75Rybrevant $74.28Krazati $71.93Vyloy $70.96Bavencio $66.78Comirnaty $65.71Monoferric $64.10Fruzaqla $63.67Onivyde $62.90Somatuline Depot $62.90Sarclisa $62.69Tivdak $62.51Tibsovo $62.27Paxlovid $61.76Lonsurf $61.62Inqovi $61.62Monjuvi $61.29Zoladex $58.63Ninlaro $58.23Jevtana $56.52Promacta $56.46Datroway $55.97Besponsa $55.77Lunsumio $53.68Carvykti $53.03Vonjo $52.36Inlyta $50.24Lynozyfic $48.18Pluvicto $47.47Ayvakit $47.15Rytelo $47.03Orgovyx $46.84Tasigna $45.87Gavreto $44.52Sylvant $42.82Empaveli $42.00Keytruda Qlex $41.87Itovebi $36.57
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Barron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.